Close Menu

The GET conference is underway in Cambridge and James Watson, one of the "personal genome pioneers" at the meeting, is letting his thoughts be known during the discussions. At this time in his life, Watson says he wasn't worried about what he might have learned from getting his genome sequenced. "If I were 20 I wouldn't want to know because you just worry. At 80 I don't worry if I'm going to get cancer," Watson said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.